Its use in cancer to date benefits from its PKC inhibiting actives as well as its selective estrogen receptor modulator property in hormone receptor-positive breast cancer (Nelson et al., 2019), while its use as a mood-stabilizer can is under development. This evidence concerns the gene PRRT2 and cancer.